BH3 profiling as pharmacodynamic biomarker for the activity of BH3 mimetics

被引：1
|
作者：
Aaron, Rongqing [1 ,2 ,3 ,4 ,5 ]
Wang, Youzhen [6 ]
Qiu, Shumei [6 ]
Villalobos-Ortiz, Mariana [4 ,5 ]
Ryan, Jeremy [4 ,5 ]
Morris, Erick [6 ]
Halilovic, Ensar [6 ]
Letai, Anthony [4 ,5 ]
机构：
[1] Zhejiang Univ, Bone Marrow Transplantat Ctr, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Hematol, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Dept Immunol, Sch Med, Hangzhou, Zhejiang, Peoples R China
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Novartis Inst Biomed Res Oncol Drug Discovery, Cambridge, MA USA
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 04期
关键词：
CELLS; DEATH;
D O I：
10.3324/haematol.2023.283060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1253 / 1258
页数：6
相关论文
共 50 条
  • [41] Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia
    Billard, C.
    LEUKEMIA, 2012, 26 (09) : 2032 - 2038
  • [42] BH3 Mimetics Can Overcome Resistance to Chemotherapy in Colorectal Cancer
    Cannon, Mary D.
    Concannon, Caoimhin
    Hector, Suzanne
    Murray, Frank E.
    Prehn, Jochen H.
    GASTROENTEROLOGY, 2010, 138 (05) : S501 - S502
  • [43] MITOPHAGY PROMOTES RESISTANCE TO BH3 MIMETICS IN ACUTE MYELOID LEUKEMIA
    Glytsou, Christina
    Chen, Xufeng
    Zacharioudakis, Emmanouil
    Nadorp, Bettina
    Lasry, Audrey
    Lee, Soobeom
    Papaioannou, Dimitrios
    Zal, Tomasz
    Tsirigos, Aristotelis
    Andreeff, Michael
    Gavathiotis, Evripidis
    Aifantis, Iannis
    EXPERIMENTAL HEMATOLOGY, 2023, 124 : S42 - S42
  • [44] Design of novel BH3 mimetics for the treatment of chronic lymphocytic leukemia
    C Billard
    Leukemia, 2012, 26 : 2032 - 2038
  • [45] Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
    Mark S. Cragg
    Claire Harris
    Andreas Strasser
    Clare L. Scott
    Nature Reviews Cancer, 2009, 9 : 321 - 326
  • [46] BH3 mimetics activate multiple pro-autophagic pathways
    Malik, S. A.
    Orhon, I.
    Morselli, E.
    Criollo, A.
    Shen, S.
    Marino, G.
    BenYounes, A.
    Benit, P.
    Rustin, P.
    Maiuri, M. C.
    Kroemer, G.
    ONCOGENE, 2011, 30 (37) : 3918 - 3929
  • [47] BH3 mimetics activate multiple pro-autophagic pathways
    S A Malik
    I Orhon
    E Morselli
    A Criollo
    S Shen
    G Mariño
    A BenYounes
    P Bénit
    P Rustin
    M C Maiuri
    G Kroemer
    Oncogene, 2011, 30 : 3918 - 3929
  • [48] Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid Leukemia
    Glytsou, Christina
    Chen, Xufeng
    Zacharioudakis, Emmanouil
    Al-Santli, Wafa
    Zhou, Hua
    Nadorp, Bettina
    Lee, Soobeom
    Lasry, Audrey
    Sun, Zhengxi
    Papaioannou, Dimitrios
    Cammer, Michael
    Wang, Kun
    Zal, Tomasz
    Zal, Malgorzata Anna
    Carter, Bing Z.
    Ishizawa, Jo
    Tibes, Raoul
    Tsirigos, Aristotelis
    Andreeff, Michael
    Gavathiotis, Evripidis
    Aifantis, Iannis
    CANCER DISCOVERY, 2023, 13 (07) : 1656 - 1677
  • [49] Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
    Cragg, Mark S.
    Harris, Claire
    Strasser, Andreas
    Scott, Clare L.
    NATURE REVIEWS CANCER, 2009, 9 (05) : 321 - 326
  • [50] BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia
    Brumatti, Gabriela
    Kaloni, Deeksha
    Castro, Fabiola Attie
    Amarante-Mendes, Gustavo P.
    BIOCHEMICAL JOURNAL, 2023, 480 (02) : 161 - 176
12345